AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1437427 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized letter reminder about the need for an influenza vaccination
Number of subjects: 124
Study 1437427 — intervention group
Group type: COMPARATOR
Intervention: No reminder
Number of subjects: 124
Study 1437427 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized letter reminder
Number of subjects: 124
Study 1437427 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental worry about asthma
Number of subjects: 124
Study 1437427 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental worry about vaccine side effects
Number of subjects: 124
Study 3839558 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (arthrotomy and medial meniscectomy)
Number of subjects: 35
Study 3839558 — intervention group
Group type: COMPARATOR
Intervention: Group II (extraarticular substitution of the anterior cruciate ligament)
Number of subjects: 35
Study 3839558 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study 31175716 — intervention group
Group type: EXPERIMENTAL
Intervention: Steam inhalation at 42-44°C
Number of subjects: 0
Study 31107728 — intervention group
Group type: EXPERIMENTAL
Intervention: More acculturated parents
Number of subjects: 117
Study 31107728 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents who perceive their child as having a weight problem
Number of subjects: 117
Study 29215806 — intervention group
Group type: EXPERIMENTAL
Intervention: LCD-based visual field testing system (LVF)
Number of subjects: 330
Study 29215806 — intervention group
Group type: COMPARATOR
Intervention: Standard automated perimetry (HFA)
Number of subjects: 330
Study 26135774 — intervention group
Group type: EXPERIMENTAL
Intervention: nsNIPPV
Number of subjects: 63
Study 26135774 — intervention group
Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 63
Study 24354541 — intervention group
Group type: EXPERIMENTAL
Intervention: Open technique (eyelid crease incision operation)
Number of subjects: 44
Study 24354541 — intervention group
Group type: COMPARATOR
Intervention: Closed technique (supralash stab incision)
Number of subjects: 44
Study 24354541 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 44
Study 23127292 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocrine therapy alone
Number of subjects: 1113
Study 23127292 — intervention group
Group type: COMPARATOR
Intervention: Chemo-endocrine therapy
Number of subjects: 1113
Study 19936714 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine 20 mg
Number of subjects: 99
Study 19936714 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (0, 5, 10, and 20 mg)
Number of subjects: 99
Study 17414392 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 1712
Study 15502669 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 1 plus $20 incentive paid at return visit
Number of subjects: 0
Study 15502669 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 1 plus motivational counseling at the first visit and a phone reminder at 3 months
Number of subjects: 0
Study 15502669 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 1 plus phone reminder
Number of subjects: 0
Study 15502669 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 1 plus motivational counseling but no telephone reminder
Number of subjects: 0
Study 15502669 — intervention group
Group type: COMPARATOR
Intervention: Intervention 1
Number of subjects: 0
Study 11335695 — intervention group
Group type: EXPERIMENTAL
Intervention: Consonant musical excerpts
Number of subjects: 1
Study 11335695 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissonant musical excerpts
Number of subjects: 1
Study 11335695 — intervention group
Group type: EXPERIMENTAL
Intervention: Chord sequences with varying degrees of dissonance
Number of subjects: 1
Study 11335695 — intervention group
Group type: COMPARATOR
Intervention: CT scan and PET activation data comparison
Number of subjects: 1
Study 9556123 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation (PC)
Number of subjects: 10
Study 9556123 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-regulated volume-controlled ventilation (PRVC)
Number of subjects: 10
Study 9556123 — intervention group
Group type: COMPARATOR
Intervention: Volume-controlled ventilation (VC)
Number of subjects: 10
Study 7984694 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisuride 1.0 mg daily dose
Number of subjects: 55
Study 7984694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 2500195 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane (0.1‐0.6% in air‐oxygen mixture)
Number of subjects: 60
Study 2500195 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (continuous intravenous infusion of 0.01‐0.20 mg/kg/h)
Number of subjects: 60
Study 31427860 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (resistance exercise plus walking, 2 times weekly for 6 months)
Number of subjects: 30
Study 25385719 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume online haemodiafiltration (HV-OL-HDF)
Number of subjects: 40
Study 25385719 — intervention group
Group type: COMPARATOR
Intervention: Standard bicarbonate dialysis (BHD)
Number of subjects: 40
Study 22340518 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (dose-escalation for three days followed by maintenance dose)
Number of subjects: 0
Study 22340518 — intervention group
Group type: COMPARATOR
Intervention: Standard care (placebo)
Number of subjects: 0
Study 21223254 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole added to aspirin
Number of subjects: 52
Study 18234433 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved field radiotherapy (IF-RT) at 30 Gy
Number of subjects: 1779
Study 18234433 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved field radiotherapy (IF-RT) at 20 Gy
Number of subjects: 1779
Study 18234433 — intervention group
Group type: COMPARATOR
Intervention: Involved field radiotherapy (IF-RT)
Number of subjects: 1779
Study 16685221 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy for blood pressure lowering
Number of subjects: 6105
Study 16685221 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-drug therapy
Number of subjects: 6105
Study 16685221 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieved follow-up BP levels
Number of subjects: 6105
Study 16685221 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower BP levels
Number of subjects: 6105
Study 15735329 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 26
Study 15735329 — intervention group
Group type: COMPARATOR
Intervention: Vestibular rehabilitation (VR)
Number of subjects: 26
Study 11341669 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine
Number of subjects: 25
Study 9236441 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous awake breathing
Number of subjects: 80
Study 9236441 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal breathing
Number of subjects: 80
Study 9236441 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodic breathing
Number of subjects: 80
Study 9236441 — intervention group
Group type: EXPERIMENTAL
Intervention: Cheyne‐Stokes respiration (CSR)
Number of subjects: 80
Study 9236441 — intervention group
Group type: COMPARATOR
Intervention: Controlled breathing
Number of subjects: 80
Study 9236441 — intervention group
Group type: COMPARATOR
Intervention: Controlled ventilation
Number of subjects: 80
Study 8237398 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol sustained-release tablets (Sino-Swed Pharmaceutical Co Ltd)
Number of subjects: 12
Study 8237398 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol tablets from Sweden Astra International Pharmaceutical Co Ltd
Number of subjects: 12
Study 2960719 — intervention group
Group type: EXPERIMENTAL
Intervention: T3 25 micrograms
Number of subjects: 16
Study 2960719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30475647 — intervention group
Group type: EXPERIMENTAL
Intervention: En masse retraction (ER)
Number of subjects: 48
Study 30475647 — intervention group
Group type: COMPARATOR
Intervention: Two-step retraction (TSR)
Number of subjects: 48
Study 29216331 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined short- and long-axis (SLA) approach
Number of subjects: 20
Study 29216331 — intervention group
Group type: COMPARATOR
Intervention: Short-axis (SA) approach
Number of subjects: 20
Study 29216331 — intervention group
Group type: COMPARATOR
Intervention: Combined short- and long-axis (SLA) approach vs Short-axis (SA) approach
Number of subjects: 20
Study 26054533 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-fraction intensity-modulated RT (1 × 24 Gy)
Number of subjects: 60
Study 26054533 — intervention group
Group type: COMPARATOR
Intervention: Fractionated RT (10 × 3 Gy)
Number of subjects: 60
Study 24127170 — intervention group
Group type: EXPERIMENTAL
Intervention: Bemiparin + matching placebo
Number of subjects: 206
Study 24127170 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 206
Study 22295543 — intervention group
Group type: COMPARATOR
Intervention: Ringer solution and 10% glucose solution in 1:1 ratio
Number of subjects: 139
Study 22295543 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterofundin-G-5 solution
Number of subjects: 139
Study 22295543 — intervention group
Group type: EXPERIMENTAL
Intervention: Remaxol (800 ml/day)
Number of subjects: 139
Study 19339148 — intervention group
Group type: EXPERIMENTAL
Intervention: MAAEZ intervention (Making Alcoholics Anonymous Easier)
Number of subjects: 508
Study 16799281 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive Health Achievable Benchmarks Curriculum (multifaceted improvement intervention including individualized performance feedback, academic detailing by faculty, and collective didactic sessions)
Number of subjects: 208
Study 16799281 — intervention group
Group type: COMPARATOR
Intervention: Control group residents (no specific intervention mentioned)
Number of subjects: 208
Study 12922105 — intervention group
Group type: EXPERIMENTAL
Intervention: Engerix B
Number of subjects: 44
Study 12922105 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepavax Gene
Number of subjects: 44
Study 12922105 — intervention group
Group type: EXPERIMENTAL
Intervention: Gen Hevac B
Number of subjects: 44
Study 10869286 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids (40 mg/d prednisolone)
Number of subjects: 71
Study 10869286 — intervention group
Group type: COMPARATOR
Intervention: Enteral nutrition (2,000 kcal/d for 28 days)
Number of subjects: 71
Study 9375539 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg methylprednisolone (MP)
Number of subjects: 45
Study 9375539 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 45
Study 8473585 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 62
Study 8473585 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic therapy
Number of subjects: 62
Study 3517407 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam (AZT) 1 g, twice a day by intravenous drip infusion for 5 days
Number of subjects: 394
Study 3517407 — intervention group
Group type: COMPARATOR
Intervention: Cefoperazone (CPZ) 1 g, twice a day by intravenous drip infusion for 5 days
Number of subjects: 394
Study 3517407 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam (AZT)
Number of subjects: 394
Study 3517407 — intervention group
Group type: COMPARATOR
Intervention: Cefoperazone (CPZ)
Number of subjects: 394
Study 3517407 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam (AZT) for Gram-negative bacteria
Number of subjects: 394
Study 3517407 — intervention group
Group type: COMPARATOR
Intervention: Cefoperazone (CPZ) for Gram-negative bacteria
Number of subjects: 394
Study 29898619 — intervention group
Group type: EXPERIMENTAL
Intervention: Obinutuzumab plus bendamustine (G + B) for up to 2 years
Number of subjects: 0
Study 29898619 — intervention group
Group type: COMPARATOR
Intervention: Bendamustine monotherapy (B-monotherapy)
Number of subjects: 0
Study 27898982 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-linked (PACK-CXL)
Number of subjects: 16
Study 27898982 — intervention group
Group type: EXPERIMENTAL
Intervention: Infected and then cross-linked (PACK-CXL)
Number of subjects: 16
Study 27898982 — intervention group
Group type: COMPARATOR
Intervention: Infected
Number of subjects: 16
Study 27898982 — intervention group
Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 16
Study 24816395 — intervention group
Group type: EXPERIMENTAL
Intervention: Ara h 2
Number of subjects: 4
Study 24816395 — intervention group
Group type: EXPERIMENTAL
Intervention: Pru p 3
Number of subjects: 4
Study 24816395 — intervention group
Group type: EXPERIMENTAL
Intervention: Ara h 1
Number of subjects: 4
Study 24816395 — intervention group
Group type: EXPERIMENTAL
Intervention: Ara h 9
Number of subjects: 4
Study 22688600 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for pain
Number of subjects: 132
Study 20714711 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task condition where observers signalled the direction of the luminance change.
Number of subjects: 4
Study 20714711 — intervention group
Group type: COMPARATOR
Intervention: Single-task condition where the discrimination stimulus was presented but could be ignored.
Number of subjects: 4
Study 18929283 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 microg kg(‐1) dexmedetomidine (group D, n = 20)
Number of subjects: 40
Study 18929283 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (group C, n = 20)
Number of subjects: 40
Study 15879168 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (HCHO)
Number of subjects: 2
Study 15879168 — intervention group
Group type: COMPARATOR
Intervention: Low carbohydrate diet (LCHO)
Number of subjects: 2
Study 15879168 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets (HCHO and LCHO)
Number of subjects: 2
Study 12410458 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly cross‐linked hyaluronic acid (HA)
Number of subjects: 111
Study 12410458 — intervention group
Group type: COMPARATOR
Intervention: Gaseous oxygen (O2)
Number of subjects: 111
Study 12410458 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 111
Study 12063216 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2-T T1-weighted SE imaging
Number of subjects: 287
Study 12063216 — intervention group
Group type: COMPARATOR
Intervention: 1.5-T MR imaging
Number of subjects: 287
Study 9874906 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline hydrochloride (NT)
Number of subjects: 0
Study 9874906 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 0
Study 9874906 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 7735371 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (somatostatin analog) for 21 days after diagnosis
Number of subjects: 20
Study 7735371 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched diabetic children)
Number of subjects: 20
Study 2646895 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg once daily
Number of subjects: 0
Study 2646895 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg once daily
Number of subjects: 0
Study 2646895 — intervention group
Group type: COMPARATOR
Intervention: Probucol 500 mg twice daily
Number of subjects: 0
Study 31300025 — intervention group
Group type: EXPERIMENTAL
Intervention: Stemless total shoulder arthroplasty
Number of subjects: 80
Study 31300025 — intervention group
Group type: COMPARATOR
Intervention: Stemmed total shoulder arthroplasty
Number of subjects: 80
Study 31300025 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 80
Study 29072162 — intervention group
Group type: EXPERIMENTAL
Intervention: Homogenized Holder-pasteurized human milk (PHHM)
Number of subjects: 8
Study 29072162 — intervention group
Group type: COMPARATOR
Intervention: Holder-pasteurized human milk (PHM)
Number of subjects: 8
Study 25307416 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping Power program
Number of subjects: 0
Study 23462537 — intervention group
Group type: EXPERIMENTAL
Intervention: Wholegrain diet for 12 weeks
Number of subjects: 146
Study 23462537 — intervention group
Group type: COMPARATOR
Intervention: Refined cereal diet for 12 weeks
Number of subjects: 146
Study 21480105 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal information
Number of subjects: 300
Study 21480105 — intervention group
Group type: EXPERIMENTAL
Intervention: Written information
Number of subjects: 300
Study 21480105 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study 17473836 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) 40,000 IU
Number of subjects: 0
Study 17473836 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 0
Study 17262143 — intervention group
Group type: EXPERIMENTAL
Intervention: OxaGel
Number of subjects: 50
Study 17262143 — intervention group
Group type: EXPERIMENTAL
Intervention: experimental agent DD‐1
Number of subjects: 50
Study 17262143 — intervention group
Group type: EXPERIMENTAL
Intervention: experimental agent DD‐2
Number of subjects: 50
Study 17262143 — intervention group
Group type: COMPARATOR
Intervention: placebo gel
Number of subjects: 50
Study 17262143 — intervention group
Group type: COMPARATOR
Intervention: deionized water
Number of subjects: 50
Study 12943433 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical assessment
Number of subjects: 31
Study 12943433 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-dimensional color transparencies
Number of subjects: 31
Study 12943433 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional imaging
Number of subjects: 31
Study 12943433 — intervention group
Group type: EXPERIMENTAL
Intervention: Lay assessors' clinical assessment
Number of subjects: 31
Study 12943433 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical assessment
Number of subjects: 31
Study 10636972 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucomannan
Number of subjects: 20
Study 10636972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9371897 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 327
Study 9371897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 327
Study 1541105 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-aided technique
Number of subjects: 56
Study 1541105 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 56
Study 31309348 — intervention group
Group type: EXPERIMENTAL
Intervention: APP+ mobile app intervention
Number of subjects: 90
Study 31309348 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 90
Study 30221194 — intervention group
Group type: EXPERIMENTAL
Intervention: GLA-AF (aqueous formulation of glucopyranosyl lipid adjuvant)
Number of subjects: 0
Study 26462806 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0
Study 26462806 — intervention group
Group type: COMPARATOR
Intervention: Nutritionally balanced amino acid mixtures
Number of subjects: 0
Study 24634299 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine and adefovir dipivoxil
Number of subjects: 77
Study 24634299 — intervention group
Group type: COMPARATOR
Intervention: Autologous bone marrow stem cell transplantation combined with lamivudine and adefovir dipivoxil
Number of subjects: 77
Study 22472173 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular delivery of 40 ml bone marrow cells (n = 21)
Number of subjects: 41
Study 22472173 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial delivery of 40 ml bone marrow cells (n = 20)
Number of subjects: 41
Study 19919585 — intervention group
Group type: EXPERIMENTAL
Intervention: MgSO(4) 60 mg/kg
Number of subjects: 80
Study 19919585 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 80
Study 18625536 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg NA/5 microg EE
Number of subjects: 485
Study 18625536 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg NA/10 microg EE
Number of subjects: 485
Study 18625536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 485
Study 16003271 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear mapping of regional myocardial strain
Number of subjects: 20
Study 16003271 — intervention group
Group type: COMPARATOR
Intervention: Arbitrary measurements
Number of subjects: 20
Study 11809593 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg/day for one year
Number of subjects: 18
Study 11809593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 10518297 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week lumbar stabilization exercise program with weekly reinstruction
Number of subjects: 44
Study 10518297 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise group (control)
Number of subjects: 44
Study 7552929 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical levocabastine
Number of subjects: 21
Study 1708719 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned MEPs with nerve-TCS intervals between 16 and 20 msec for elbow stimulation
Number of subjects: 0
Study 1708719 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned MEPs with nerve-TCS intervals between 20 and 22 msec for wrist stimulation
Number of subjects: 0
Study 1708719 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned MEPs with nerve-TCS intervals corresponding to the sum of AT + CI (mean 23.2 msec, range 21.7-24.8)
Number of subjects: 0
Study 1708719 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated conditioned MEPs
Number of subjects: 0
Study 1708719 — intervention group
Group type: COMPARATOR
Intervention: Segmental H reflex
Number of subjects: 0
Study 6114279 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbitone
Number of subjects: 60
Study 6114279 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 30969147 — intervention group
Group type: EXPERIMENTAL
Intervention: TIPS-Plus
Number of subjects: 240
Study 30969147 — intervention group
Group type: COMPARATOR
Intervention: TIPS-Basic
Number of subjects: 240